https://www.selleckchem.com/products/wh-4-023.html
NLC formulations had a better corneal permeation rate than the marketed product during 6 h of ex vivo studies. Conclusions According to in vitro and ex vivo data, it was determined that the most favorable NLC formulation was the formulation containing BHL/SBE-CD that was covered with chitosan. It has the highest drug loading capacity and one of the highest ex vivo corneal passage levels, along with desired drug release. The formulation containing BHL/SBE-CD and chitosan can be a potential alternative for the treatment of bacterial kera
Like
Comment
Share
